Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

Stopped early · Phase 2

Conditions studied: Sarcoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus sargramostim in treating patients who have advanced, persistent, or recurrent cancer of the uterus.

Key facts

Study ID

NCT00033644

Run by

Gynecologic Oncology Group

Starts

2002-03-01

Last updated by the study team

2013-04-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• Tuft-New England Medical Center — Boston, Massachusetts, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Cooper University Hospital — Camden, New Jersey, United States
• State University of New York Health Sciences Center - Stony Brook — Stony Brook, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
• Barrett Cancer Center — Cincinnati, Ohio, United States
• University of Oklahoma College of Medicine — Oklahoma City, Oklahoma, United States
• Abington Memorial Hospital — Abington, Pennsylvania, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• Tacoma General Hospital — Tacoma, Washington, United States
• Norwegian Radium Hospital — Oslo, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.